1. Home
  2. LAW vs PROK Comparison

LAW vs PROK Comparison

Compare LAW & PROK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CS Disco Inc.

LAW

CS Disco Inc.

HOLD

Current Price

$3.79

Market Cap

259.6M

Sector

Technology

ML Signal

HOLD

Logo ProKidney Corp.

PROK

ProKidney Corp.

HOLD

Current Price

$1.76

Market Cap

229.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LAW
PROK
Founded
2013
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
259.6M
229.9M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
LAW
PROK
Price
$3.79
$1.76
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
5
Target Price
$8.00
$7.40
AVG Volume (30 Days)
325.7K
752.2K
Earning Date
05-06-2026
03-18-2026
Dividend Yield
N/A
N/A
EPS Growth
22.58
N/A
EPS
N/A
N/A
Revenue
$156,849,000.00
$893,000.00
Revenue This Year
$11.23
N/A
Revenue Next Year
$10.60
$25.00
P/E Ratio
N/A
N/A
Revenue Growth
8.29
1075.00
52 Week Low
$2.45
$0.46
52 Week High
$9.11
$7.13

Technical Indicators

Market Signals
Indicator
LAW
PROK
Relative Strength Index (RSI) 41.71 38.67
Support Level $2.45 $1.71
Resistance Level $4.63 $2.58
Average True Range (ATR) 0.22 0.14
MACD -0.02 -0.04
Stochastic Oscillator 16.35 24.69

Price Performance

Historical Comparison
LAW
PROK

About LAW CS Disco Inc.

CS Disco Inc provides a cloud-native, artificial intelligence-powered legal solution that simplifies discovery, legal document review, and case management for enterprises, law firms, legal services providers, and governments. Its revenue-generating activities directly relate to the sale and support of legal solutions. It has two primary types of contractual arrangements: usage-based and subscription solutions. The usage-based revenue is derived from contracts under which customers are billed monthly based on their usage. Subscription revenue is derived from contracts where customers are contractually committed to a minimum data volume over a period of time.

About PROK ProKidney Corp.

ProKidney Corp is a clinical-stage biotechnology company pioneering the development of a first-in-class, autologous cell therapy that is intended to preserve kidney function in patients with advance chronic kidney disease (CKD) and diabetes. Its product candidate, REACT (Renal Autologous Cell Therapy), is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.

Share on Social Networks: